share_log

海吉亞醫療:2024年中期報告

HYGEIA HEALTH: INTERIM REPORT 2024

HKEX ·  Sep 24 21:26

Summary by Futu AI

海吉亞醫療於二零二四年六月三十日公佈中期財務報告,顯示期內收入達人民幣2,381.9百萬元,同比增長35.4%;毛利為人民幣756.4百萬元,同比增加32.5%;淨利潤為人民幣385.2百萬元,同比增加15.0%。報告期內,公司管理或經營16家以腫瘤科為核心的醫院,覆蓋中國8個省的13個城市。公司繼續專注於腫瘤醫療服務,並通過內生性增長及戰略收購,擴大業務覆蓋範圍。此外,公司於報告期後無重大事項。
海吉亞醫療於二零二四年六月三十日公佈中期財務報告,顯示期內收入達人民幣2,381.9百萬元,同比增長35.4%;毛利為人民幣756.4百萬元,同比增加32.5%;淨利潤為人民幣385.2百萬元,同比增加15.0%。報告期內,公司管理或經營16家以腫瘤科為核心的醫院,覆蓋中國8個省的13個城市。公司繼續專注於腫瘤醫療服務,並通過內生性增長及戰略收購,擴大業務覆蓋範圍。此外,公司於報告期後無重大事項。
hygeia health announced its interim financial report on June 30, 2024, showing that the revenue reached RMB 2,381.9 million, a year-on-year increase of 35.4%; gross profit was RMB 756.4 million, an increase of 32.5% year-on-year; net profit was RMB 385.2 million, an increase of 15.0% year-on-year. During the reporting period, the company managed or operated 16 hospitals with oncology as the core, covering 13 cities in 8 provinces in china. The company continues to focus on oncology medical services, expanding its business coverage through organic growth and strategic acquisitions. In addition, there were no significant events after the reporting period.
hygeia health announced its interim financial report on June 30, 2024, showing that the revenue reached RMB 2,381.9 million, a year-on-year increase of 35.4%; gross profit was RMB 756.4 million, an increase of 32.5% year-on-year; net profit was RMB 385.2 million, an increase of 15.0% year-on-year. During the reporting period, the company managed or operated 16 hospitals with oncology as the core, covering 13 cities in 8 provinces in china. The company continues to focus on oncology medical services, expanding its business coverage through organic growth and strategic acquisitions. In addition, there were no significant events after the reporting period.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.